| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 03/17/2009 | US7504386 comprised of benzyl esters of hyaluronic acid and/or internally cross-linked derivatives of hyaluronic acid and may be in the form of gels, membranes, woven tissues or meshes and nonwoven tissues; adhesion prevention |
| 03/12/2009 | WO2009005790A3 Sterile thiol-derivatized hyaluronic acid polymer compositions and uses thereof |
| 03/11/2009 | EP1173567B1 Tribonectins |
| 03/05/2009 | WO2009028965A1 Surgical hydrogel |
| 03/05/2009 | WO2009028559A1 Water-absorbing polymer particle and method for producing water-absorbing polymer particle |
| 03/05/2009 | US20090062249 An intraocular, biodegradable drug delivery system comprising anecortave acetate and a biodegradable glycolic acid-lactic acid copolymer effective in releasing the immunosuppressant into the eye over a period of > 3 weeks; sustained release from a single pellet or a single extruded filament |
| 03/05/2009 | US20090060975 Containment system for delivery of biological products and method of surgery |
| 03/05/2009 | CA2709546A1 Surgical hydrogel |
| 03/04/2009 | CN101378766A Composition for inhibiting adhesion |
| 03/04/2009 | CN100465186C A composition and a method for inhibiting platelet aggregation |
| 03/03/2009 | US7498406 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 03/03/2009 | US7498334 Pyrrolopyrimidines as phosphodiesterase VII inhibitors |
| 03/03/2009 | US7498034 Imaging, diagnosis and treatment of disease |
| 02/26/2009 | WO2009002768A3 Liquid bandage |
| 02/26/2009 | US20090054302 Methods and Preparations For Curing Clinically Ill Patients |
| 02/19/2009 | US20090047317 Disinfectant Delivery System and Method of Providing Alcohol-Free Disinfection |
| 02/19/2009 | US20090047292 Graft rejection suppressors |
| 02/18/2009 | EP1208097B1 Substituted oxoazaheterocyclyl compounds |
| 02/18/2009 | CN101366724A Filling liquid after uterine lumen surgery |
| 02/18/2009 | CN101366723A Medicinal composition |
| 02/17/2009 | US7491677 Composite sample on support; concentration gradients |
| 02/12/2009 | US20090042199 Nucleotide sequences coding lymphocyte adhesion protein for use in treatment of autoimmunity, inflammation and infection |
| 02/12/2009 | CA2693237A1 Composition and method for treatment of reperfusion injury and tissue damage |
| 02/11/2009 | CN101365478A Use of c1 inhibitor for the prevention of ischemia-reperfusion injury |
| 02/11/2009 | CN101361751A Moisture absorption self-adhesion barrier film capable of preventing postoperative adhesions and preparation method thereof |
| 02/10/2009 | US7488739 platelet aggregation inhibitors; anti-platelet agent with a high safety profile with a smaller adverse bleeding effect; P2Y12 inhibitor; (2S)-2-({[7-(cyclohexylamino)-1-cyclopentyl-6-fluoro-4-oxo-1,4-dihydroquinolin-3-yl]carbonyl}amino)butanedioic acid |
| 02/05/2009 | US20090035257 Devices, compositions and methods for the protection and repair of cells and tissues |
| 01/29/2009 | WO2009012534A1 Improved organ protection, preservation and recovery |
| 01/29/2009 | US20090028867 Antagonists Specific For Denatured Collagen And Methods Of Using Same |
| 01/29/2009 | US20090028813 Methods for Treating Body Tissue |
| 01/29/2009 | CA2731398A1 Improved organ protection, preservation and recovery |
| 01/28/2009 | CN101352453A Pharmaceutical composition for preventing intestinal adhesion |
| 01/28/2009 | CN101352452A Pharmaceutical composition capable of preventing and treating oviduct adhesions |
| 01/27/2009 | US7482013 Albumin fusion proteins |
| 01/22/2009 | US20090023662 recognize extracellular structures of G protein-coupled receptors; for treating humoral kidney rejection |
| 01/22/2009 | US20090023659 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/15/2009 | US20090018102 Phamaceutical/cosmetic compositions comprising hyaluronic acid and treatment of dermatological conditions therewith |
| 01/15/2009 | US20090018068 G-protein coupled receptors |
| 01/14/2009 | EP1307541B1 Tissue implant for cartilage repair |
| 01/13/2009 | CA2470466C Combinations of viscoelastics for use during surgery |
| 01/08/2009 | WO2009005790A2 Sterile thiol-derivatized hyaluronic acid polymer compositions and uses thereof |
| 01/08/2009 | US20090011978 Use of Surfactant Preparations for the Treatment of Surgical Adhesions |
| 01/07/2009 | EP2011877A2 Conjugates for the modulation of immune responses |
| 01/07/2009 | CN101336910A Chlorhexidine composition with colouring function |
| 01/07/2009 | CN100448440C Protective solution for preventing local ischemic damage |
| 01/06/2009 | CA2404335C Vitamin d compounds used to stabilize kidney transplants |
| 01/01/2009 | US20090005347 Via bisphosphonate drug; for prophylaxis of cartilage destruction or chondrolysis associated with osteonecrosis and/or osteochondritis dissecans |
| 12/31/2008 | EP2007371A1 Lactate and calcium containing pharmaceutical composition and uses thereof |
| 12/31/2008 | EP1309610B1 Peptide and peptide mimetic derivatives with integrin inhibitor properties ii |
| 12/30/2008 | CA2368767C Protease resistant flint analogs |
| 12/30/2008 | CA2327398C Methods and compositions for stabilizing acetylcholine compositions |
| 12/24/2008 | WO2008157323A1 Antimicrobial film-forming composition, antimicrobial film, and method of verifying the presence of an antimicrobial film |
| 12/24/2008 | CN101327344A Carboxymethyl chitosan hydrogel material and production method thereof |
| 12/24/2008 | CN100445296C Polypeptide organic compounds and application in xenogeneic transplantation |
| 12/18/2008 | WO2008153159A1 Amine compound and pharmaceutical use thereof |
| 12/18/2008 | US20080311188 Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol |
| 12/18/2008 | CA2690686A1 Amine compound and pharmaceutical use thereof |
| 12/17/2008 | EP1385504B1 Method of inhibiting adhesion formation |
| 12/11/2008 | WO2008148867A2 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases |
| 12/11/2008 | US20080305993 Use of C1 Inhibitor for the Prevention of Ischemia-Reperfusion Injury |
| 12/11/2008 | CA2690288A1 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases |
| 12/11/2008 | CA2688525A1 Biological tissue growth through induced tensile stress |
| 12/10/2008 | EP2000472A1 Rapamycin Analogs Containing an Antioxidant Moiety |
| 12/10/2008 | EP2000471A1 Rapamycin Analogs Containing an Antioxidant Moiety |
| 12/10/2008 | EP2000470A1 Rapamycin Analogs Containing an Antioxidant Moiety |
| 12/10/2008 | EP2000136A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors |
| 12/10/2008 | EP1492501B1 Methods of using lamellar bodies for therapeutic purposes |
| 12/09/2008 | US7462606 Antiseptics; surgery; controlling release of drugs |
| 12/03/2008 | EP1996219A2 Treatment of ischemic disease using thrombopoietin |
| 11/27/2008 | US20080293034 Organ arrest, protection, preservation and recovery |
| 11/27/2008 | US20080292683 Film shreds and delivery system incorporating same |
| 11/27/2008 | US20080292579 Polymer-Based Serum Albumin Substitute |
| 11/20/2008 | WO2008138232A1 Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof |
| 11/20/2008 | US20080287520 Use of Melatonin in Preventing Postoperative Complications |
| 11/20/2008 | CA2685757A1 Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof |
| 11/19/2008 | EP1992350A2 Medical composition comprising a polysaccharide for elevating the epithelium |
| 11/18/2008 | CA2402652C Viscoelastics for use in middle ear surgery |
| 11/18/2008 | CA2340417C Methods for forming regional tissue adherent barriers and drug delivery systems |
| 11/06/2008 | WO2008134544A1 Compositions for prevention of adhesions and other barrier applications |
| 11/06/2008 | WO2008132233A1 Composition, methods and kits for prevention of adhesion |
| 11/06/2008 | US20080274045 Imaging, diagnosis and treatment of disease |
| 11/06/2008 | CA2722465A1 Compositions for prevention of adhesions and other barrier applications |
| 11/05/2008 | EP1986714A1 Coronary stent that releases medicamentuous composition to prevent and treat restenosis and fabrication process |
| 11/05/2008 | EP1162990B1 Treatment with small peptides to effect antifibrotic activity |
| 11/05/2008 | EP1104323B1 Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby |
| 11/04/2008 | US7446091 Methods and preparations for curing clinically ill patients |
| 10/30/2008 | US20080269128 Albumin Fusion Proteins |
| 10/30/2008 | US20080269127 Albumin Fusion Proteins |
| 10/30/2008 | US20080269126 Albumin Fusion Proteins |
| 10/30/2008 | US20080269125 Albumin Fusion Proteins |
| 10/30/2008 | US20080268042 Omega 3 fatty acid formulations |
| 10/30/2008 | US20080267962 Albumin Fusion Proteins |
| 10/30/2008 | US20080267902 Blood products with binding agent |
| 10/28/2008 | US7442383 N-methyl D-aspartic acid (NMDA) receptor antagonism; neuroprotection |
| 10/23/2008 | US20080261877 Albumin Fusion Proteins |
| 10/23/2008 | US20080260820 Providing effective gastrointestinal tract drug delivery; therapeutic protein having primary amino acid sequence modification |
| 10/23/2008 | US20080260752 Prevention and reduction of blood loss |
| 10/23/2008 | US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood |
| 10/23/2008 | US20080260710 Using chemotherapeutic inoculation and neutrophil extraction as tools in prevention infection in digestive system organ |